Phase 3 study of (177)Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION) Meeting Abstract


Authors: Krause, B.; de Bono, J.; Chi, K. N.; Fizazi, K.; Herrmann, K.; Rahbar, K.; Tagawa, S. T.; Nordquist, L. T.; Vaishampayan, N.; El-Haddad, G.; Park, C. H.; Beer, T. M.; Pérez-Contreras, W. J.; DeSilvio, M.; Kpamegan, E.; Gericke, G.; Messmann, R. A.; Morris, M. J.; Sartor, O.
Abstract Title: Phase 3 study of (177)Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
Meeting Title: 2021 Annual Congress of the European Association of Nuclear Medicine (EANM'21)
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 48
Issue: Suppl. 1
Meeting Dates: 2021 Oct 20-23
Meeting Location: Virtual
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2021-09-01
Start Page: S63
Language: English
ACCESSION: WOS:000709355000086
PROVIDER: wos
PMCID: PMC8461591
PUBMED: 34559267
DOI: 10.1007/s00259-021-05547-1
Notes: Meeting Abstract: OP-0170 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris